Detalhe da pesquisa
1.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636444
2.
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitors.
Br J Clin Pharmacol
; 88(9): 4171-4179, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437784
3.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253871
4.
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis.
Oncologist
; 26(4): 302-309, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336844
5.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424148
6.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698790
7.
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
Oncologist
; 24(10): 1395-1402, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952821
8.
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.
Pharmacogenomics J
; 19(5): 455-464, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686821
9.
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
Oncologist
; 23(10): 1178-1187, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739893
10.
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Cancer
; 123(22): 4506-4514, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708932
11.
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Br J Cancer
; 116(3): 318-323, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081548
12.
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 21(8): 988-94, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27382031
13.
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm.
Crit Rev Oncol Hematol
; 186: 103985, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059274
14.
Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial).
Updates Surg
; 75(6): 1579-1587, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160552
15.
Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
Cancers (Basel)
; 15(8)2023 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190129
16.
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients.
Tumori
; 109(5): 481-489, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609197
17.
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Clin Colorectal Cancer
; 22(3): 339-343.e3, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429749
18.
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001711
19.
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.
Front Oncol
; 13: 1307545, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406172
20.
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence.
Cancers (Basel)
; 15(19)2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835377